COVID-19 vaccine weekly safety report (23 June 2022)

23 June 2022 - To 19 June 2022, the TGA has received 581 reports which have been assessed as likely to ...

Read more →

Prescription medicines: applications under evaluation

21 June 2022 - The TGA has updated its list of applications for new medicines or new uses for existing ...

Read more →

IP waiver for COVID vaccines is a threat to future innovation

20 June 2022 - The decision to waive intellectual property protections for COVID-19 vaccines is fundamentally flawed and will have ...

Read more →

COVID-19 vaccine weekly safety report (16 June 2022)

16 June 2022 - To 12 June 2022, the TGA has received 584 reports which have been assessed as likely to ...

Read more →

TGA approves Vyxeos

15 June 2022 - This marks the first TGA approval for Jazz Pharmaceuticals. ...

Read more →

TGA approval of Kimmtrak

15 June 2022 - Tebentafusp is a bi-specific fusion protein. ...

Read more →

Novavax COVID-19 vaccine Nuvaxovid provisionally registered in Australia as a booster in individuals aged 18 and over

13 June 2022 - In Australia, Nuvaxovid is the first protein-based COVID-19 vaccine registered for use as a booster regardless ...

Read more →

IP waiver for COVID vaccines misses the mark in vaccinating the world

14 June 2022 - Vaccinating the world remains a priority and proposals to weaken the intellectual property for COVID-19 vaccines ...

Read more →

COVID-19 vaccine weekly safety report (9 June 2022)

9 June 2022 - To 5 June 2022, the TGA has received 577 reports which have been assessed as likely to ...

Read more →

The UK MHRA, Australian TGA and Health Canada approve Kimmtrak (tebentafusp) for the treatment of unresectable or metastatic uveal melanoma

8 June 2022 - Kimmtrak demonstrated statistically and clinically meaningful overall survival benefit, hazard ratio of 0.51, with median overall survival ...

Read more →

COVID mRNA vaccines can be quickly updated for new variants. So, where's my Omicron booster?

6 June 2022 - Since Omicron was declared a variant of concern at the end of November, it quickly swept ...

Read more →

Medigen applies for Australian vaccine approval

7 June 2022 - Medigen Vaccine Biologics has applied to the Australian medicines regulator for provisional approval of its COVID-19 ...

Read more →

COVID-19 vaccine weekly safety report (2 June 2022)

2 June 2022 - To 29 May 2022, the TGA has received 573 reports which have been assessed as likely to ...

Read more →

ATAGI update following weekly COVID-19 meeting (25 May 2022)

27 May 2022 - An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 25 ...

Read more →

COVID-19 vaccine weekly safety report (26 May 2022)

26 May 2022 - To 22 May 2022, the TGA has received 555 reports which have been assessed as likely to ...

Read more →